Related Experiment Video
Updated: Dec 3, 2025

Making, Testing, and Using Potassium Ion Selective Microelectrodes in Tissue Slices of Adult Brain
Published on: May 7, 2018
Gastrointestinal potassium binding in hemodialysis.
Biff F Palmer1, Deborah J Clegg2
1Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Hyperkalemia is a serious risk for dialysis patients. New potassium-binding drugs may help manage potassium levels safely during and between dialysis sessions.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Hyperkalemia is a significant risk factor for mortality in patients undergoing dialysis.
- Dietary potassium restriction is often insufficient and limits intake of heart-healthy foods.
- Reducing dialysate potassium concentration may increase arrhythmia risk.
Purpose of the Study:
- To discuss the findings of Amdur et al. regarding potassium management in dialysis patients.
- To explore the potential of potassium-binding drugs for maintaining normal plasma potassium levels.
Main Methods:
- Commentary discussing existing research and clinical implications.
- Analysis of strategies for managing hyperkalemia in dialysis patients.
Main Results:
- Amdur et al. highlight challenges in current hyperkalemia management.
- Potassium-binding drugs show promise for stable potassium control.
Conclusions:
- Potassium-binding drugs offer a potential strategy to maintain safe plasma potassium levels during interdialytic and intradialytic periods.
- This approach may improve patient outcomes by avoiding dietary restrictions and intradialytic arrhythmias.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis II: Procedure and Complications
Acute Kidney Injury V: Interprofessional Care
Hemodialysis I: Introduction
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...

